Agios Pharmaceuticals, Inc. carries a market capitalization of 2.16B, placing it among publicly traded companies globally.
| Market Cap | 2.16B |
| Enterprise Value | N/A |
Agios Pharmaceuticals, Inc.'s stock has gained approximately 6.96657% over the past 52 weeks. The 50-day moving average sits at 26.18, while the 200-day moving average is 24.83.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6.96657% |
| 50-Day Moving Average | 26.18 |
| 200-Day Moving Average | 24.83 |
| Average Volume (20 Days) | N/A |